, Thailand
1 view

Thailand to become the medicine hub of Southeast Asia

Japanese drugmakers are interested in establishing their main manufacturing sites in Thailand.

Thailand has been a key exporter of medicines within Southeast Asia with a value of $474.5m in 2019. That is forecast to grow even further over the next five years, according to a Fitch Solutions report, to $502m by 2024. A large share of these exports (57%) go to neighboring countries including Vietnam, Myanmar, Cambodia, and the Philippines. As these countries are on the way to expanding their healthcare access, the Thai pharmaceutical demand is increasing.

The increase in demand has also attracted multinational firms to establish and expand their manufacturing operations in the country. Japanese drugmakers, in particular, are signaling strong intentions to establish Thailand as their chief manufacturing site for producing and repackaging medicinal products for Southeast Asia.

The formation of the ASEAN Economic Community (AEC) is also expected to support the country’s development as a key exporter of medicines in the region. Though integration is expected to be a gradual process, the harmonisation of pharmaceutical regulations and the elimination of technical barriers will allow drugmakers to better export products from Thailand.

The Thai government has also put a complete regulatory framework in place to support local research and development activities such as derivations of blood, vaccine, proteins and Advanced Therapy Medical Products (ATMP) such as cell therapy products, gene therapy products and stem cell therapy products, including the Cell Therapy Act.

All these efforts will incentivise local companies to invest more in the R&D sector which is currently reined by multinational firms like Pfizer, Sanofi, and GlaxoSmithKline, the report added.

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.